PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Tenbusch, M.* ; Schumacher, S.* ; Vogel, E. ; Priller, A.* ; Held, J.* ; Steininger, P.* ; Beileke, S.* ; Irrgang, P.* ; Brockhoff, R.* ; Salmanton-García, J.* ; Tinnefeld, K. ; Mijočević, H. ; Schober, K.* ; Bogdan, C.* ; Yazici, S.* ; Knolle, P.* ; Cornely, O.A.* ; Überla, K.* ; Protzer, U.

Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.

Lancet Infect. Dis. 21, 1212-1213 (2021)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
25.071
8.275
14
34
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 1473-3099
e-ISSN 1474-4457
Journal The Lancet. Infectious diseases
Quellenangaben Volume: 21, Issue: 9, Pages: 1212-1213 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place The Boulevard, Langford Lane, Kidlington, Oxford Ox5 1gb, Oxon, England
Reviewing status Peer reviewed
Institute(s) Institute of Virology (VIRO)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-502700-003
DOI 10.1016/S1473-3099(21)00420-5
WOS ID WOS:000690453300019
Scopus ID 85113402279
PubMed ID 34332707
Erfassungsdatum 2021-09-09
[➜Report correction]